Neurotech startup and Neuralink competitor Paradromics secures strategic investment from Saudi Arabia’s Neom - Tech Startups
Summary
Texas-based neurotech startup Paradromics announced on Wednesday it has secured strategic investment from Saudi Arabias Neom. Another startup is Synchron, a New York-based brain interface company backed by Bill Gates and Jeff Bezos, which is also advancing human trials for its mind-controlled computing.Paradromics is developing a brain-computer interfacea system that reads brain signals and converts them into commands for external devices. The startup plans to collaborate with Neom to push forward BCI-based therapies and set up what it calls the premier center for BCI-based healthcare in the Middle East and North Africa.Paradromics is one of several companies in the race to bring BCIs to market, alongside big names like Elon Musks Neuralink. Other players in the space include Precision Neuroscience and Synchronthe latter backed by Jeff Bezos and Bill Gatesboth of which have also conducted human implants.So far, none of these companies have received final approval from the U.S. Food and Drug Administration (FDA).Paradromics own BCI, the Connexus Direct Data Interface, uses an array of tiny electrodes implanted directly into brain tissue. While it hasnt secured full FDA approval yet, Paradromics did receive the FDAs Breakthrough Device designation in 2023, signaling that its technology holds promise for addressing unmet medical needs.Neom, located in northwest Saudi Arabia, was unveiled in 2017 by Crown Prince Mohammad bin Salman.